Skip to main content
. 2017 Sep 12;8(44):77860–77871. doi: 10.18632/oncotarget.20842

Table 1. Genotype distribution of single nucleotide polymorphisms of carbonic anhydrase 9 gene in patients with uterine cervical cancer or normal women.

Variables Control (n=327) Cervical cancer(n=123) p value OR (95% CI)b Adjusted OR(95% CI)c
rs2071676
GGd 79 (24.2%) 26 (22.8%) 0.109 1.00 1.00
AG 171 (52.3%) 56 (43.6%) 1.00 (0.58-1.70) 0.72 (0.39-1.34)
AA 77 (23.5%) 41 (33.6%) 1.62 (0.90-2.90) 1.27 (0.65-2.48)
GGd 79 (24.2%) 26 (22.8%) 0.500 1.00 1.00
GA/AA 248 (75.8%) 97 (77.2%) 1.19 (0.72-1.96) 1.13 (0.63-2.00)
GG/GAd 250 (76.5%) 82 (66.7%) 0.035a 1.00 1.00
AA 77 (23.5%) 41 (33.3%) 1.62 (1.03-2.56) 1.59 (0.93-2.70)
rs3829078
AAd 297 (90.8%) 114 (92.7%) 0.717 1.00 1.00
AG 29 (8.9%) 9 (7.3%) 0.81 (0.37-1.76) 0.84 (0.34-2.06)
GG 1 (0.3%) 0 (0%) u.a. u.a.
AAd 297 (90.8%) 114 (92.7%) 0.533 1.00 1.00
AG/GG 30 (9.2%) 9 (7.3%) 0.78 (0.36-1.70) 0.79 (0.32-1.93)
AA/AGd 326 (99.7%) 123 (100%) 0.539 1.00 1.00
GG 1 (0.3%) 0 (0%) u.a. u.a.
rs1048638
CCd 292 (89.3%) 98 (79.7%) 0.011a 1.00 1.00
CA 33 (10.1%) 25 (20.3%) 2.26 (1.28-3.98) 1.98 (1.03-3.79)
AA 2 (0.6%) 0 (0%) u.a. u.a.
CCd 292 (89.3%) 98 (79.7%) 0.007a 1.00 1.00
CA/AA 35 (10.7%) 25 (20.3%) 2.13 (1.21-3.73) 1.92 (1.01-3.65)
CC/CAd 325 (99.4%) 123 (100%) 1.000 1.00 1.00
AA 2 (0.6%) 0 (0%) u.a. u.a.
376deletion393
Ins/Insd 249 (76.1%) 96 (78.0%) 0.651 1.00 1.00
Ins/del 76 (23.3%) 27 (22.0%) 0.92 (0.56-1.52) 0.86 (0.47-1.57)
Del/del 2 (0.6%) 0 (0%) u.a. u.a.
Ins/Insd 249 (76.1%) 96 (78.0%) 0.671 1.00 1.00
Ins/del or del/del 78 (23.9%) 27 (22.0%) 0.90 (0.55-1.48) 0.84 (0.46-1.52)
Ins/Ins or ins/deld 325 (99.4%) 123 (100%) 1.000 1.00 1.00
Del/del 2 (0.6%) 0 (0%) u.a. u.a.

Statistical analysis: logistic regression model or chi-square or Fisher's exact tests, ap < 0.05.

bComparison between patients with uterine cervical cancer and control women.

cThe adjusted OR with their 95% CI was estimated by logistic regression models after controlling for age between cancer patients and control women.

dUsed as a reference for comparison to evaluate the odds ratio of other genotypes.

OR, odds ratio; 95% CI, 95% confidence interval. Del, deletion; ins, insertion; u.a., unavailable.